CN Stock MarketDetailed Quotes

002393 Tianjin Lisheng Pharmaceutical

Watchlist
  • 25.87
  • -0.52-1.97%
Not Open May 15 15:00 CST
4.77BMarket Cap12.73P/E (TTM)

Tianjin Lisheng Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
8.71%364.85M
0.56%1.15B
1.06%911.57M
6.95%657.49M
9.51%335.6M
5.00%1.15B
7.94%902.02M
4.67%614.74M
-6.45%306.46M
-4.29%1.09B
Operating revenue
8.71%364.85M
0.56%1.15B
1.06%911.57M
6.95%657.49M
9.51%335.6M
5.00%1.15B
7.94%902.02M
4.67%614.74M
-6.45%306.46M
-4.29%1.09B
Other operating revenue
----
27.25%7.7M
----
-23.81%2.01M
----
29.70%6.05M
----
-53.14%2.64M
----
72.35%4.67M
Total operating cost
7.78%309.28M
-3.00%969.53M
-1.25%760.76M
5.88%563.85M
10.39%286.96M
3.83%999.48M
5.23%770.42M
1.67%532.52M
-10.97%259.94M
-9.41%962.61M
Operating cost
30.87%172.14M
-3.73%468.15M
-3.67%352.76M
2.57%249.52M
6.70%131.53M
7.00%486.28M
4.75%366.19M
-0.74%243.27M
-10.19%123.28M
3.41%454.48M
Operating tax surcharges
11.24%6.06M
-5.13%22.87M
-2.80%17.27M
-2.51%12M
-13.95%5.45M
7.44%24.11M
6.24%17.76M
10.38%12.31M
6.54%6.33M
-4.17%22.44M
Operating expense
-4.68%96.43M
-5.08%318.94M
-1.83%273.17M
6.73%198.8M
16.28%101.17M
-7.41%336.02M
5.39%278.27M
1.68%186.26M
-13.94%87M
-14.49%362.91M
Administration expense
1.23%27.54M
-0.74%113.61M
-2.87%77.16M
10.36%55.63M
19.27%27.2M
8.17%114.46M
0.57%79.44M
-1.56%50.41M
-7.91%22.81M
-16.16%105.81M
Financial expense
-653.75%-17.48M
11.43%-59.66M
38.22%-37.2M
26.90%-17.75M
55.40%-2.32M
22.68%-67.36M
-7.14%-60.21M
6.93%-24.28M
-123.03%-5.2M
-214.93%-87.12M
-Interest expense (Financial expense)
616.85%922.02K
-14.78%745.83K
-16.04%490.57K
-14.68%374.92K
79.63%128.62K
173.07%875.18K
115.77%584.32K
220.04%439.45K
-14.50%71.6K
-39.52%320.5K
-Interest Income (Financial expense)
-632.56%-18.41M
11.32%-60.53M
37.93%-37.78M
26.57%-18.22M
52.81%-2.51M
22.09%-68.25M
-7.55%-60.86M
5.77%-24.81M
-122.15%-5.33M
-207.77%-87.6M
Research and development
2.74%24.58M
-0.33%105.62M
-12.77%77.6M
1.70%65.65M
-6.99%23.93M
1.82%105.98M
12.65%88.97M
9.00%64.55M
1.90%25.73M
35.71%104.09M
Credit Impairment Loss
-67.70%25.07K
216.03%2.62M
1,282.87%305.48K
726.66%161.84K
--77.59K
-7,149.54%-2.26M
-183.17%-25.83K
-156.89%-25.83K
----
106.75%32.01K
Asset Impairment Loss
----
-48.97%-29.25M
----
----
----
-30.06%-19.63M
---2.31M
----
----
78.56%-15.1M
Other net revenue
40.77%9.1M
913.65%236.31M
3,325.14%252.91M
76.21%11.3M
53.58%6.47M
-483.04%-29.04M
-54.03%7.38M
-44.68%6.41M
-48.86%4.21M
116.05%7.58M
Fair value change income
----
122.02%621.77K
----
----
----
--280.06K
----
----
----
----
Invest income
32.69%8.2M
-34.54%15.5M
49.54%12.09M
85.18%10.56M
51.68%6.18M
23.04%23.68M
-29.64%8.08M
-26.77%5.7M
-44.28%4.08M
18.92%19.25M
-Including: Investment income associates
81.51%6.48M
6.19%11.02M
23.10%8.66M
49.07%7.34M
-12.39%3.57M
-20.85%10.38M
-9.67%7.03M
-36.78%4.92M
-44.28%4.08M
13.56%13.11M
Asset deal income
----
785.53%238.7M
--238.61M
--14.74K
--14.74K
---34.82M
----
----
----
----
Other revenue
357.53%873.27K
118.82%8.11M
16.61%1.91M
-23.68%560.61K
42.59%190.87K
9.05%3.71M
-57.37%1.64M
-75.98%734.57K
-85.39%133.86K
-54.52%3.4M
Operating profit
17.35%64.67M
255.57%419.81M
190.49%403.73M
18.40%104.94M
8.63%55.11M
-13.76%118.06M
16.20%138.98M
17.91%88.63M
15.65%50.73M
341.22%136.91M
Add:Non operating Income
-88.51%129.91K
59.40%560.9K
192.71%1.35M
163.15%1.2M
1,775.89%1.13M
-43.21%351.88K
42.89%461.94K
106.49%455.04K
7.37%60.29K
109.05%619.6K
Less:Non operating expense
931.90%17.06K
193.06%152.26K
5,082.02%106.94K
4,826.96%101.68K
1,553.63%1.65K
-87.25%51.95K
-99.34%2.06K
-99.04%2.06K
-99.92%100
3.37%407.4K
Total profit
15.20%64.78M
255.02%420.21M
190.43%404.97M
19.03%106.03M
10.73%56.24M
-13.68%118.36M
16.57%139.44M
18.51%89.08M
15.98%50.79M
343.30%137.12M
Less:Income tax cost
-8.51%8.91M
135.83%58.39M
132.33%62.31M
-7.46%15.85M
10.21%9.74M
64.89%24.76M
22.44%26.82M
23.06%17.13M
14.19%8.83M
-32.72%15.01M
Net profit
20.16%55.88M
286.54%361.83M
204.26%342.67M
25.33%90.18M
10.84%46.5M
-23.34%93.61M
15.26%112.62M
17.47%71.95M
16.36%41.95M
1,317.31%122.11M
Net profit from continuing operation
20.16%55.88M
286.54%361.83M
204.26%342.67M
25.33%90.18M
10.84%46.5M
-23.34%93.61M
15.26%112.62M
17.47%71.95M
16.36%41.95M
1,317.31%122.11M
Less:Minority Profit
---3.28M
----
----
----
----
----
----
----
----
----
Net profit of parent company owners
27.22%59.16M
286.54%361.83M
204.26%342.67M
25.33%90.18M
10.84%46.5M
-23.34%93.61M
15.26%112.62M
17.47%71.95M
16.36%41.95M
1,317.31%122.11M
Earning per share
Basic earning per share
28.00%0.32
286.27%1.97
200.00%1.86
25.64%0.49
8.70%0.25
-23.88%0.51
14.81%0.62
14.71%0.39
15.00%0.23
1,240.00%0.67
Diluted earning per share
28.00%0.32
286.27%1.97
200.00%1.86
25.64%0.49
8.70%0.25
-23.88%0.51
14.81%0.62
14.71%0.39
15.00%0.23
1,240.00%0.67
Other composite income
329.93%238.67M
-1,847.70%-103.8M
108.85%5.94M
Other composite income of parent company owners
----
329.93%238.67M
----
----
----
-1,847.70%-103.8M
----
----
----
108.85%5.94M
Total composite income
20.16%55.88M
5,992.10%600.49M
204.26%342.67M
25.33%90.18M
10.84%46.5M
-107.96%-10.19M
15.26%112.62M
17.47%71.95M
16.36%41.95M
318.78%128.04M
Total composite income of parent company owners
27.22%59.16M
5,992.10%600.49M
204.26%342.67M
25.33%90.18M
10.84%46.5M
-107.96%-10.19M
15.26%112.62M
17.47%71.95M
16.36%41.95M
318.78%128.04M
Total composite income of minority owners
---3.28M
----
----
----
----
----
----
----
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 8.71%364.85M0.56%1.15B1.06%911.57M6.95%657.49M9.51%335.6M5.00%1.15B7.94%902.02M4.67%614.74M-6.45%306.46M-4.29%1.09B
Operating revenue 8.71%364.85M0.56%1.15B1.06%911.57M6.95%657.49M9.51%335.6M5.00%1.15B7.94%902.02M4.67%614.74M-6.45%306.46M-4.29%1.09B
Other operating revenue ----27.25%7.7M-----23.81%2.01M----29.70%6.05M-----53.14%2.64M----72.35%4.67M
Total operating cost 7.78%309.28M-3.00%969.53M-1.25%760.76M5.88%563.85M10.39%286.96M3.83%999.48M5.23%770.42M1.67%532.52M-10.97%259.94M-9.41%962.61M
Operating cost 30.87%172.14M-3.73%468.15M-3.67%352.76M2.57%249.52M6.70%131.53M7.00%486.28M4.75%366.19M-0.74%243.27M-10.19%123.28M3.41%454.48M
Operating tax surcharges 11.24%6.06M-5.13%22.87M-2.80%17.27M-2.51%12M-13.95%5.45M7.44%24.11M6.24%17.76M10.38%12.31M6.54%6.33M-4.17%22.44M
Operating expense -4.68%96.43M-5.08%318.94M-1.83%273.17M6.73%198.8M16.28%101.17M-7.41%336.02M5.39%278.27M1.68%186.26M-13.94%87M-14.49%362.91M
Administration expense 1.23%27.54M-0.74%113.61M-2.87%77.16M10.36%55.63M19.27%27.2M8.17%114.46M0.57%79.44M-1.56%50.41M-7.91%22.81M-16.16%105.81M
Financial expense -653.75%-17.48M11.43%-59.66M38.22%-37.2M26.90%-17.75M55.40%-2.32M22.68%-67.36M-7.14%-60.21M6.93%-24.28M-123.03%-5.2M-214.93%-87.12M
-Interest expense (Financial expense) 616.85%922.02K-14.78%745.83K-16.04%490.57K-14.68%374.92K79.63%128.62K173.07%875.18K115.77%584.32K220.04%439.45K-14.50%71.6K-39.52%320.5K
-Interest Income (Financial expense) -632.56%-18.41M11.32%-60.53M37.93%-37.78M26.57%-18.22M52.81%-2.51M22.09%-68.25M-7.55%-60.86M5.77%-24.81M-122.15%-5.33M-207.77%-87.6M
Research and development 2.74%24.58M-0.33%105.62M-12.77%77.6M1.70%65.65M-6.99%23.93M1.82%105.98M12.65%88.97M9.00%64.55M1.90%25.73M35.71%104.09M
Credit Impairment Loss -67.70%25.07K216.03%2.62M1,282.87%305.48K726.66%161.84K--77.59K-7,149.54%-2.26M-183.17%-25.83K-156.89%-25.83K----106.75%32.01K
Asset Impairment Loss -----48.97%-29.25M-------------30.06%-19.63M---2.31M--------78.56%-15.1M
Other net revenue 40.77%9.1M913.65%236.31M3,325.14%252.91M76.21%11.3M53.58%6.47M-483.04%-29.04M-54.03%7.38M-44.68%6.41M-48.86%4.21M116.05%7.58M
Fair value change income ----122.02%621.77K--------------280.06K----------------
Invest income 32.69%8.2M-34.54%15.5M49.54%12.09M85.18%10.56M51.68%6.18M23.04%23.68M-29.64%8.08M-26.77%5.7M-44.28%4.08M18.92%19.25M
-Including: Investment income associates 81.51%6.48M6.19%11.02M23.10%8.66M49.07%7.34M-12.39%3.57M-20.85%10.38M-9.67%7.03M-36.78%4.92M-44.28%4.08M13.56%13.11M
Asset deal income ----785.53%238.7M--238.61M--14.74K--14.74K---34.82M----------------
Other revenue 357.53%873.27K118.82%8.11M16.61%1.91M-23.68%560.61K42.59%190.87K9.05%3.71M-57.37%1.64M-75.98%734.57K-85.39%133.86K-54.52%3.4M
Operating profit 17.35%64.67M255.57%419.81M190.49%403.73M18.40%104.94M8.63%55.11M-13.76%118.06M16.20%138.98M17.91%88.63M15.65%50.73M341.22%136.91M
Add:Non operating Income -88.51%129.91K59.40%560.9K192.71%1.35M163.15%1.2M1,775.89%1.13M-43.21%351.88K42.89%461.94K106.49%455.04K7.37%60.29K109.05%619.6K
Less:Non operating expense 931.90%17.06K193.06%152.26K5,082.02%106.94K4,826.96%101.68K1,553.63%1.65K-87.25%51.95K-99.34%2.06K-99.04%2.06K-99.92%1003.37%407.4K
Total profit 15.20%64.78M255.02%420.21M190.43%404.97M19.03%106.03M10.73%56.24M-13.68%118.36M16.57%139.44M18.51%89.08M15.98%50.79M343.30%137.12M
Less:Income tax cost -8.51%8.91M135.83%58.39M132.33%62.31M-7.46%15.85M10.21%9.74M64.89%24.76M22.44%26.82M23.06%17.13M14.19%8.83M-32.72%15.01M
Net profit 20.16%55.88M286.54%361.83M204.26%342.67M25.33%90.18M10.84%46.5M-23.34%93.61M15.26%112.62M17.47%71.95M16.36%41.95M1,317.31%122.11M
Net profit from continuing operation 20.16%55.88M286.54%361.83M204.26%342.67M25.33%90.18M10.84%46.5M-23.34%93.61M15.26%112.62M17.47%71.95M16.36%41.95M1,317.31%122.11M
Less:Minority Profit ---3.28M------------------------------------
Net profit of parent company owners 27.22%59.16M286.54%361.83M204.26%342.67M25.33%90.18M10.84%46.5M-23.34%93.61M15.26%112.62M17.47%71.95M16.36%41.95M1,317.31%122.11M
Earning per share
Basic earning per share 28.00%0.32286.27%1.97200.00%1.8625.64%0.498.70%0.25-23.88%0.5114.81%0.6214.71%0.3915.00%0.231,240.00%0.67
Diluted earning per share 28.00%0.32286.27%1.97200.00%1.8625.64%0.498.70%0.25-23.88%0.5114.81%0.6214.71%0.3915.00%0.231,240.00%0.67
Other composite income 329.93%238.67M-1,847.70%-103.8M108.85%5.94M
Other composite income of parent company owners ----329.93%238.67M-------------1,847.70%-103.8M------------108.85%5.94M
Total composite income 20.16%55.88M5,992.10%600.49M204.26%342.67M25.33%90.18M10.84%46.5M-107.96%-10.19M15.26%112.62M17.47%71.95M16.36%41.95M318.78%128.04M
Total composite income of parent company owners 27.22%59.16M5,992.10%600.49M204.26%342.67M25.33%90.18M10.84%46.5M-107.96%-10.19M15.26%112.62M17.47%71.95M16.36%41.95M318.78%128.04M
Total composite income of minority owners ---3.28M------------------------------------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg